Table 2

Comorbidities by intervention arm

ComorbiditiesFace-to-face n (%)Online n (%)
Hypertension7 (26.9%)23 (35.9%)
Cardiovascular disease13 (50%)22 (34.3%)
Cerebrovascular disease1 (3.8%)5 (7.8%)
Dermatological07 (10.9%)
Diabetes and endocrine6 (23.1%)14 (21.9%)
Gastroenterological5 (19.2%)21 (32.8%)
Haematological1 (3.8%)1 (1.6%)
Neurological and psychiatric3 (11.5%)11 (17.2%)
History of malignancy3 (11.5%)4 (6.3%)
Musculoskeletal7 (25.9%)9 (14.1%)
Renal2 (7.7%)2 (3.1%)
Other respiratory1 (3.8%)3 (4.7%)
None3 (11.5%)4 (6.3%)